Table 1.
Demographic characteristics of gynecologic cancer cases.
| Characteristics | Cases (With Cancer) (n = 97,736) |
Controls (Without Cancer) (n = 390,944) |
|---|---|---|
| Age | ||
| Mean ± SD | 50.81 ± 13.86 | 50.81 ± 13.86 |
| 20–39 y, n (%) | 22,313 (22.83) | 89,252 (22.83) |
| 40–64 y, n (%) | 58,062 (59.41) | 232,248 (59.41) |
| >=65 y, n (%) | 17,361 (17.76) | 69,444 (17.76) |
| Comorbid conditions, n (%) | ||
| Myocardial infarction | 194 (0.20) | 774 (0.20) |
| Congestive heart failure | 1473 (1.51) | 6331 (1.62) |
| Peripheral vascular disease | 602 (0.62) | 2932 (0.75) |
| Cerebrovascular disease | 3723 (3.81) | 17,466 (4.47) |
| Dementia | 627 (0.64) | 3427 (0.88) |
| Chronic pulmonary disease | 2680 (2.74) | 12,665 (3.24) |
| Rheumatic disease | 1363 (1.39) | 6472 (1.66) |
| Peptic ulcer disease | 10,245 (10.48) | 49,475 (12.66) |
| Liver disease | 5058 (5.18) | 24,268 (6.20) |
| Diabetes | 11,622 (11.89) | 55,471 (14.19) |
| Hemiplegia or paraplegia | 157 (0.16) | 770 (0.20) |
| Renal disease | 2019 (2.07) | 8880 (2.27) |
| CCI score | ||
| Mean ± SD | 0.46 ± 0.82 | 0.52 ± 0.92 |
| Other drugs, n (%) | ||
| Metformin | 6817 (6.97) | 33,423 (8.55) |
| Aspirin | 6226 (6.37) | 29,946 (7.66) |
| Statin | 7613 (7.79) | 40,040 (10.24) |
CCI, Charlson comorbidity index.